Skip to content
BGLC BioNexus Gene Lab Corp Common stock
$1.51 -1.95% -0.03
Notify me if price changes either direction
Interactive Brokers Logotype

Buy BGLC stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 3.7M
Enterprise value 104.3K
Trailing PE -0.93341630367144
PEG Ratio 0.0261356565028
Enterprise to EBITDA -0.035
Enterprise to revenue 0.02
Price to book MRQ 0.45997608
Price to sales TTM 0.70097697

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 5.3M
EBITDA -2961790
Diluted EPS TTM -1.49
Total Cash (MRQ) 4.0M
Current ratio (MRQ) 6.524
Operating Cash Flow (TTM) -1161981

BGLC trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent BGLC News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.